Vanda and FDA's agreement includes expedited re-reviews of Tradipitant and Hetlioz applications, with target action dates in late 2025 and early 2026. The collaborative framework involves pausing ...
The lack of mechanisms for multidisciplinary follow-up care after TBI is a key gap identified in the 2022 National Academies’ TBI report. To make progress toward addressing this gap, this Action ...
The Action Collaborative on Medical Operation Coordination Centers (AC-MOCCs) is working to enhance the impact and readiness of medical operation coordination centers (MOCCs) by aligning key ...